Epicrispr Biotechnologies
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7000 Shoreline Ct Ste 100, South San Fra...Website
www.epicrispr.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Epicrispr Biotechnologies
Epicrispr Biotechnologies is a clinical-stage biotechnology company developing gene-modulating therapies for serious diseases. The company uses CRISPR, epigenetic editing, genetic engineering, and computational technologies to precisely control gene expression, with a pipeline focused on neuromuscular and other genetic disorders.Explore more
Epicrispr Biotechnologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Epicrispr Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Epicrispr Biotechnologies is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Epicrispr Biotechnologies launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Epicrispr Biotechnologies
Earning: See what the market has to say on Epicrispr Biotechnologies recently announced quarterly report
Click to see if Epicrispr Biotechnologies had a recent Job posting/layoffs
Epicrispr Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Epicrispr Biotechnologies has new funding data
Check if Epicrispr Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Epicrispr Biotechnologies as Masked Content
Find more new buyers
Epicrispr Biotechnologies financials insights
Gather financial insights about Epicrispr Biotechnologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$55M
2025
Series B
$68M
2026
Series C
$90M
Epicrispr Biotechnologies Tech Stack
A closer look at the technologies used by Epicrispr Biotechnologies
See more technologies
Most Recent Scoops
Open Position
Hiring Plans
Epicrispr Biotechnologies has more open roles in Medical & Health than it has had at any time in the past 12 months with an increased focus that include Clinical Trial Development, Clinical System Operations, and Biotechnology, and experience with ICH Guidelines, Clinical Trial Management Systems, Clinical Program Development, and Clinical Research.
Hiring Plans
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Project
Research & Development, Product Management, Intellectual Property, Medical Research, Pharmaceuticals, Clinical Operations
Funding
Funding
Epicrispr Biotechnologies News & Media
Epicrispr Biotechnologies Named Finalist in XPRIZE Healthspan Competition FSHD Bonus Prize
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #FSHD--Epicrispr Biotechnologies Named Finalist in XPRIZE Healthspan Competition FSHD Bonus PrizeEpicrispr Biotechnologies Announces Five Presentations Highlighting Advances in Epigenetic Modulation and AAV Manufacturing at ASGCT 2025 Annual Meeting
SAN FRANCISCO--(BUSINESS WIRE)-- #ASGCT25--Epicrispr Announces Five Presentations Highlighting Advances in Epigenetic Modulation and AAV Manufacturing at ASGCT 2025 Annual MeetingEpicrispr Biotechnologies Partners with Springbok Analytics to Integrate AI Muscle Analysis in First-in-Human FSHD Study
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #FSHD--Epicrispr Biotechnologies Partners with Springbok Analytics to Integrate AI Muscle Analysis in First-in-Human FSHD Study
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Epicrispr Biotechnologies
Sign Up For FreeTo access detailed company insights
Epicrispr Biotechnologies is a clinical-stage biotechnology company developing gene-modulating therapies for serious diseases. The company uses CRISPR, epigenetic editing, genetic engineering, and computational technologies to precisely control gene expression, with a pipeline focused on neuromuscular and other genetic disorders.... Read More
